Compliance-Certificate under Regulation 74(5) of SEBI (DP) Regulation,2018
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences has submitted a routine compliance certificate to BSE for the quarter ended 31 March 2025. The certificate, issued by the company's Registrar and Share Transfer Agent (Beetal Financial & Computer Services), confirms that all share certificates received for dematerialisation during the quarter were properly processed and accepted/rejected by the depositories. It also confirms that the physical certificates have been mutilated and cancelled, and the depository's name has been substituted as the registered owner in the company's member register within the SEBI-mandated 15-day window. This is a standard procedural filing required under SEBI's depository regulations.
No material impact on the stock or shareholders. This is a routine quarterly compliance disclosure confirming proper handling of dematerialisation requests and does not affect the company's financial position or operations.